Augmentation of in vivo antitumour activity of xenogeneic antiserum by autotransplanted normal spleen cells in mice.

[1]  H. Cantor,et al.  Direct evidence that natural killer cells in nonimmune spleen cell populations prevent tumor growth in vivo , 1979, The Journal of experimental medicine.

[2]  P. Klein,et al.  Antibody-dependent lysis of tumor cells in vivo. I. Early lysis of tumor cells. , 1978, Journal of the National Cancer Institute.

[3]  E. Thomas.  Marrow transplantation for acute leukemia , 1978, Cancer.

[4]  M. Brunda,et al.  Suppression of growth of guinea pig line-10 hepatocarcinoma. II. Effect of passive transfer of xenogeneic and syngeneic antibodies and normal lymphoid cells. , 1978, Journal of immunology.

[5]  R. Metzgar,et al.  Immunotherapy of murine leukemia. I. protection against friend leukemia virus‐induced disease by passive serum therapy , 1978, International journal of cancer.

[6]  M. Kende,et al.  Therapy of AKR leukemia with antibody-dependent normal lymphocytes and cyclophosphamide , 1977, Cancer Immunology, Immunotherapy.

[7]  N. Suciu-Foca,et al.  Changes in physiology of enhanced SaI. , 1977, Transplantation Proceedings.

[8]  G. Pasternack,et al.  Immunotherapy of cancer with antibody. , 1976, Science.

[9]  M. Meltzer,et al.  Suppression of tumor growth in strain 2 guinea pigs by xenogeneic antitumor antibody. , 1976, Journal of the National Cancer Institute.

[10]  D. Pressman,et al.  Suppression of in vivo growth of mouse myelomas by purified rabbit antibodies against mouse myeloma cells. , 1974, Journal of the National Cancer Institute.

[11]  J. Fahey,et al.  Antibody-mediated in vivo suppression of EL4 leukemia in a syngeneic host. , 1974, Journal of the National Cancer Institute.

[12]  J. Watkins,et al.  Evidence against the Presence of H2 Histocompatibility Antigens in Ehrlich Ascites Tumour Cells , 1970, Nature.

[13]  J. Kawiak,et al.  In vivo activity of spleen cells from untreated syngeneic mice against Ehrlich ascites carcinoma. , 1979, Folia biologica.

[14]  M. Marus̆ić.  Immune mechanisms in Ehrlich ascites tumor growth in mice. , 1979, European journal of cancer.

[15]  S. Wells,et al.  Immunologic control of the ascites of murine adenocarcinoma 755. I. Protection with syngeneic immune serum or lymphoid cells. , 1978, Journal of the National Cancer Institute.

[16]  M. Farber,et al.  Enhancement of growth of allogeneic mouse tumor by the IgG1 fraction of alloantibody preparations. , 1978, Journal of the National Cancer Institute.